Influence of UKBB Deal at Play in Affymetrix's New 100K-Sample MVP ...

12-11-2013 GenomeWebComments (0)

AffymetrixBiotechnology

Affymetrix executives in recent weeks have predicted that the firm's agreement with the UK Biobank to genotype its 500,000-sample collection on its Axiom platform could sway other biorepositories to choose its arrays for similar projects. That appears ...

Read more on GenomeWeb

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top